Skip to Content
Merck
  • Current dilemmas and controversies in allergic contact dermatitis to ophthalmic medications.

Current dilemmas and controversies in allergic contact dermatitis to ophthalmic medications.

Clinics in dermatology (2011-04-19)
Elena S Novitskaya, Simon J Dean, Jennifer P Craig, Anton B Alexandroff
ABSTRACT

Identifying contact allergens in ophthalmic medications can be a challenging and daunting experience. We summarize data on topical ophthalmic medications with the potential to cause periorbital contact dermatitis and allergic conjunctivitis, highlighting current dilemmas and controversies in this area. The following groups of allergens are reviewed: preservatives, antiglaucoma medications (prostaglandin analogues, β-blockers, carbonic anhydrase inhibitors, parasympathomimetics, sympathomimetics), antiinflammatory medications (nonsteroidal antiinflammatory drugs, corticosteroids), antibiotics, antivirals, antiallergic medications (antihistamines, cromones), anaesthetics, mydriatics, and cycloplegics.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
1,1,1-Trichloro-2-methyl-2-propanol hemihydrate, meets analytical specification of Ph. Eur., BP, NF, 98-100.5% (calc with ref. to anhyd. subst.)